Search results
Showing 466 to 480 of 873 results for community guidance
sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the...
No evidence of surveillance of healthcare-associated infections in the community is currently available in the UK. A qualitative study...
non-IgE-mediated food allergies in children and young people in primary care and community settings and when food allergies may be...
applicable) Why this is important:- Many people in contact with the community-based criminal justice services have significant mental...
(both urethral and suprapubic) are commonly used in both hospital and community care settings. Long-term catheterisation carries a...
significant differences in mortality or service outcomes, and did not consider community care resources or unpaid...
This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.
Everolimus for preventing organ rejection in liver transplantation (TA348)
Evidence-based recommendations on everolimus (Certican) for preventing organ rejection in adults having a liver transplant.
management of pain in children and young people with cerebral palsy in a community setting? Any explanatory notes(if applicable) Why...
loss:- What is the predictive value of risk tools for identifying people in the community who are atincreased risk of developing chronic...
multiagency working and how GPs can support transitions from hospital to the community for this population.Qualitative studies gauging...
involvement of local community in designing changes- ongoing 'ownership' by local community- management and maintenance....
clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome?...
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)
This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.
NG142/3 Question What are the benefits of planned, regular community-based reviews compared with as-required review of non-cancer...